SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells (original) (raw)

• Achcar Rde O, Cagle PT, Jagirdar J . (2007). Expression of activated and latent signal transducer and activator of transcription 3 in 303 non-small cell lung carcinomas and 44 malignant mesotheliomas: possible role for chemotherapeutic intervention. Arch Pathol Lab Med 131: 1350–1360.
  PubMed Google Scholar
• Adhikari AS, Agarwal N, Iwakuma T . (2011). Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci 16: 1927–1938.
  Article CAS Google Scholar
• Albonici L, Doldo E, Palumbo C, Orlandi A, Bei R, Pompeo E et al. (2009). Placenta growth factor is a survival factor for human malignant mesothelioma cells. Int J Immunopathol Pharmacol 22: 389–401.
  Article CAS PubMed Google Scholar
• Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-Heffernan JA et al. (2007). Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18: 2004–2013.
  Article CAS PubMed Google Scholar
• Bais C, Wu X, Yao J, Yang S, Crawford Y, McCutcheon K et al. (2010). PlGF blockade does not inhibit angiogenesis during primary tumor growth. Cell 141: 166–177.
  Article CAS PubMed Google Scholar
• Ben-Porath I, Weinberg RA . (2004). When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113: 8–13.
  Article CAS PubMed PubMed Central Google Scholar
• Campisi J . (2001). Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11: S27–S31.
  Article CAS PubMed Google Scholar
• Casarsa C, Bassani N, Ambrogi F, Zabucchi G, Boracchi P, Biganzoli E et al. (2011). Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma. Cancer Lett 302: 136–143.
  Article CAS PubMed Google Scholar
• Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B et al. (2010). Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16: 45–55.
  Article CAS PubMed Google Scholar
• Cioce M, Gherardi S, Viglietto G, Strano S, Blandino G, Muti P et al. (2010). Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle 9: 2878–2887.
  Article CAS PubMed Google Scholar
• Coppe JP, Desprez PY, Krtolica A, Campisi J . (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5: 99–118.
  Article CAS PubMed PubMed Central Google Scholar
• Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J et al. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853–2868.
  Article CAS PubMed Google Scholar
• Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY . (2007). MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433–8438.
  Article CAS PubMed Google Scholar
• Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O . (2009). Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798–1806.
  Article CAS PubMed Google Scholar
• Fujino S, Yokoyama A, Kohno N, Hiwada K . (1996). Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells. Am J Respir Cell Mol Biol 14: 508–515.
  Article CAS PubMed Google Scholar
• Galffy G, Mohammed KA, Dowling PA, Nasreen N, Ward MJ, Antony VB . (1999). Interleukin 8: an autocrine growth factor for malignant mesothelioma. Cancer Res 59: 367–371.
  CAS PubMed Google Scholar
• Hazarika M, White Jr RM, Booth BP, Wang YC, Ham DY, Liang CY et al. (2005). Pemetrexed in malignant pleural mesothelioma. Clin Cancer Res 11: 982–992.
  CAS PubMed Google Scholar
• He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447: 1130–1134.
  Article CAS PubMed PubMed Central Google Scholar
• Hermeking H . (2007). p53 enters the microRNA world. Cancer Cell 12: 414–418.
  Article CAS PubMed Google Scholar
• Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Beuschel SL, Butnor KJ et al. (2010). Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Ann N Y Acad Sci 1203: 7–14.
  Article CAS PubMed PubMed Central Google Scholar
• Huang C, Jiang T, Zhu L, Liu J, Cao J, Huang KJ et al. (2011a). STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo. Int J Oncol 38: 1637–1644.
  CAS PubMed Google Scholar
• Huang C, Yang G, Jiang T, Zhu G, Li H, Qiu Z . (2011b). The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro. Neoplasma 58: 396–405.
  Article CAS PubMed Google Scholar
• Kim C, Kim DG, Park SH, Hwang YI, Jang SH, Kim CH et al. (2011). Epithelial to mesenchymal transition of mesothelial cells in tuberculous pleurisy. Yonsei Med J 52: 51–58.
  Article CAS PubMed Google Scholar
• Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S et al. (2011). Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer.
• Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J et al. (2011). Epigenetic silencing of microRNA-34b/c lays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 17: 4965–4974.
  Article CAS PubMed Google Scholar
• Laberge RM, Awad P, Campisi J, Desprez PY . (2011). Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron.
• Li Q, Yano S, Ogino H, Wang W, Uehara H, Nishioka Y et al. (2007). The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice. Clin Cancer Res 13: 5918–5925.
  Article CAS PubMed Google Scholar
• Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F et al. (2011). Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 71: 614–624.
  Article CAS PubMed PubMed Central Google Scholar
• Ma I, Allan AL . (2011). The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 7: 292–306.
  Article CAS Google Scholar
• Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M et al. (2011). Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29: 32–45.
  Article CAS PubMed Google Scholar
• Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K et al. (1992). p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res 52: 2610–2615.
  CAS PubMed Google Scholar
• Mor O, Yaron P, Huszar M, Yellin A, Jakobovitz O, Brok-Simoni F et al. (1997). Absence of p53 mutations in malignant mesotheliomas. Am J Respir Cell Mol Biol 16: 9–13.
  Article CAS PubMed Google Scholar
• Mujoomdar AA, Tilleman TR, Richards WG, Bueno R, Sugarbaker DJ . (2010). Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: Result in a cohort of 203 resection specimens. J Thorac Cardiovasc Surg 140: 352–355.
  Article CAS PubMed Google Scholar
• Oka M, Sakaguchi M, Okada T, Nagai H, Ozaki M, Yoshioka T et al. (2010). Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells. Exp Dermatol 19: e50–e55.
  Article PubMed Google Scholar
• Park JS, Kim YS, Jee YK, Myong NH, Lee KY . (2003). Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-alpha and interleukin-1 beta. Scand J Immunol 57: 463–469.
  Article CAS PubMed Google Scholar
• Pompeo E, Albonici L, Doldo E, Orlandi A, Manzari V, Modesti A et al. (2009). Placenta growth factor expression has prognostic value in malignant pleural mesothelioma. Ann Thorac Surg 88: 426–431.
  Article PubMed Google Scholar
• Rodier F, Kim SH, Nijjar T, Yaswen P, Campisi J . (2005). Cancer and aging: the importance of telomeres in genome maintenance. Int J Biochem Cell Biol 37: 977–990.
  Article CAS PubMed Google Scholar
• Ruco LP, de Laat PA, Matteucci C, Bernasconi S, Sciacca FM, van der Kwast TH et al. (1996). Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma. J Pathol 179: 266–271.
  Article CAS PubMed Google Scholar
• Scarpa S, Giuffrida A, Palumbo C, Coletti A, Cerrito MG, Vasaturo F et al. (2002). Retinoic acid inhibits fibronectin and laminin synthesis and cell migration of human pleural mesothelioma in vitro. Oncol Rep 9: 205–209.
  CAS PubMed Google Scholar
• Schindler C, Levy DE, Decker T . (2007). JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282: 20059–20063.
  Article CAS PubMed Google Scholar
• Schramm A, Opitz I, Thies S, Seifert B, Moch H, Weder W et al. (2010). Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. Eur J Cardiothorac Surg 37: 566–572.
  Article PubMed Google Scholar
• Sidi R, Pasello G, Opitz I, Soltermann A, Tutic M, Rehrauer H et al. (2011). Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. Eur J Cancer 47: 326–332.
  Article CAS PubMed Google Scholar
• Sivertsen S, Hadar R, Elloul S, Vintman L, Bedrossian C, Reich R et al. (2006). Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer 54: 309–317.
  Article PubMed Google Scholar
• Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H et al. (2010). Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma. Int J Cancer 127: 1948–1957.
  Article CAS PubMed Google Scholar
• Takeda K, Akira S . (2000). STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev 11: 199–207.
  Article CAS PubMed Google Scholar
• Tolnay E, Kuhnen C, Wiethege T, Konig JE, Voss B, Muller KM . (1998). Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma. J Cancer Res Clin Oncol 124: 291–296.
  Article CAS PubMed Google Scholar
• Wang L, Park P, Zhang H, La Marca F, Lin CY . (2011). Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer 128: 294–303.
  Article CAS PubMed Google Scholar
• Yao J, Wu X, Zhuang G, Kasman IM, Vogt T, Phan V et al. (2011). Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy. Proc Natl Acad Sci USA 108: 11590–11595.
  Article CAS PubMed PubMed Central Google Scholar
• Young AR, Narita M . (2009). SASP reflects senescence. EMBO Rep 10: 228–230.
  Article CAS PubMed PubMed Central Google Scholar